Clinical Trial Update: Oral Lactobacillus Reuteri for Skin Barrier Dysfunction in Obesity [NA]

View source ↗

Summary

A clinical trial is evaluating oral Lactobacillus reuteri for skin barrier dysfunction in individuals with obesity. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Skin Barrier to Water Loss, Microbial Colonization | NA | Status: NOT_YET_RECRUITING